Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells.
about
T-bet and Eomesodermin in NK Cell Development, Maturation, and FunctionPositive and negative regulation by NK cells in cancerNatural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation.Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade.Adaptations of Natural Killer Cells to Self-MHC Class I.CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells.Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity.Cytokine therapy reverses NK cell anergy in MHC-deficient tumorsMechanisms of interferon-γ production by neutrophils and its function during Streptococcus pneumoniae pneumonia.Combined IL-15 and IL-12 drives the generation of CD34(+)-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transferIL-12/15/18-preactivated NK cells suppress GvHD in a mouse model of mismatched hematopoietic cell transplantationInteraction of natural killer cells with neutrophils exerts a significant antitumor immunity in hematopoietic stem cell transplantation recipientsCytokine activation induces human memory-like NK cellsNK Cell-Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by CytokinesA novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing miceRetargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity.Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies.In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer.PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma.The anti-tumor role of NK cells in vivo pre-activated and re-stimulated by interleukins in acute lymphoblastic leukemia.NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma.Phenotype of NK-Like CD8(+) T Cells with Innate Features in Humans and Their Relevance in Cancer Diseases.Transcription factors involved in the regulation of natural killer cell development and function: an update.Umbilical cord blood graft engineering: challenges and opportunities.The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity.Modulation of innate immunity in the tumor microenvironment.Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse.IgG1 anti-epidermal growth factor receptor antibodies induce CD8-dependent antitumor activity.What Fuels Natural Killers? Metabolism and NK Cell ResponsesNK Cell Exhaustion.Persistent infection due to a small-colony variant of Burkholderia pseudomallei leads to PD-1 upregulation on circulating immune cells and mononuclear infiltration in viscera of experimental BALB/c mice.Murine NK cell intrinsic cytokine-induced memory-like responses are maintained following homeostatic proliferationTumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and Eomesodermin.The breast tumor microenvironment alters the phenotype and function of natural killer cellsThe transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells.NK cell exhaustion: bad news for chronic disease?Reversal of natural killer cell exhaustion by TIM-3 blockade.Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions.
P2860
Q26744548-B3B303BB-4A8E-457F-855C-C9D567E01350Q27004658-58628BCA-5CCC-44BE-829E-40B828573A62Q33600093-6A796655-67EE-4732-ADC8-81052CBA2894Q33714165-6ACF4FA2-B0F0-4F7F-9158-1E697EABAF8AQ33931619-8CEAC1C6-F3BC-4CBD-9D35-0C0756E3EC4FQ34688644-98E8D68B-42AB-4E9F-B372-41BE2F76F27DQ35034803-3C082218-A55E-4888-8F40-B3D53A1FA5D2Q35140125-E94A8A6C-D5E5-481C-8C7F-DA05AE71696AQ35207708-74125AAE-F950-44FA-9F20-D3B8EF7F763DQ35799180-C4E026F1-4B58-4664-8335-195876F6D1E0Q36393953-F6D6AC39-F0ED-4183-AECC-A7A4367EF4C5Q36451574-D7174BAC-22F9-4E1E-AA71-729791415A3EQ36462384-58E9FD56-6403-4E8E-84DB-DAC52C9DA79DQ36759187-C93FE969-6E34-4EE7-B60B-989C5852335BQ37222176-59DF16E8-5D4D-40D8-A41B-E1DC1214028EQ37434670-587E0ACD-13B5-4297-89A0-7BAE2EF1D6D6Q37535232-5F647238-147C-4F31-B979-4481DA400CB7Q37625627-0EFDCD3F-888F-4F80-BFFF-581EEC1AAD98Q37687323-90FAFA4A-E8D6-4DC5-AE05-127E128A6C04Q37694772-D03B08F8-3B17-4509-BD02-B080F610D424Q37708827-DC6FFA82-B090-4291-8BAB-E38ABAD48351Q37721209-320A3D13-FD42-4825-A9AA-AC4253D164F0Q38054090-C9C4E8BE-322F-4D76-A9A5-FA1F3B09371BQ38514503-C7A64B88-EF99-43FC-9887-F08EE85C123FQ38670431-EE5F7AFF-6DF6-4301-9386-E655860AB79EQ38727251-B9640419-315E-4797-A229-40ED2EA017C4Q38877110-CFF6A2C6-7CD7-4225-9304-08DD157A6293Q38973867-485568BF-584A-4028-9789-B128E02ABB21Q38982777-E840FB78-9E83-4469-A83A-8A468C3580FCQ39249602-F6F65F94-A33D-4A18-ADE3-437AC3FC846CQ39431541-1183D13C-5B02-4EB8-B31E-8563842E6846Q39443383-6304D4AF-7ECC-4A80-B796-F02381232C7AQ40020711-2435911E-0EF1-4C65-8BB9-523F6E897139Q40113311-8E66C9FE-8C42-4732-B38C-E7E9CC97338FQ40965304-ECA3809D-0512-449E-A070-C36A91C4CA3DQ41049892-82A330A3-BA32-4B2D-9B7E-D56E625F203AQ42262891-0BDF3462-61F9-48CC-ACF4-5C3CCB2F4EB5Q43139021-0B545EE5-A5E6-4CF6-A069-074A9DF33587Q43180026-0D6E5010-7215-464F-92A4-FCFD2DF6AD11Q44837814-CB1CCE33-A5D6-4636-ABD0-A6995373A4DB
P2860
Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Rapid development of exhaustio ...... d murine natural killer cells.
@ast
Rapid development of exhaustio ...... d murine natural killer cells.
@en
type
label
Rapid development of exhaustio ...... d murine natural killer cells.
@ast
Rapid development of exhaustio ...... d murine natural killer cells.
@en
prefLabel
Rapid development of exhaustio ...... d murine natural killer cells.
@ast
Rapid development of exhaustio ...... d murine natural killer cells.
@en
P2093
P2860
P1433
P1476
Rapid development of exhaustio ...... d murine natural killer cells.
@en
P2093
Aaron T Smith
Adrianne E Vasey
Alysha De Souza
David S Ritchie
Holbrook E Kohrt
Jeanette Baker
Kenneth D Gibbs
Mareike Florek
Robert S Negrin
P2860
P304
P356
10.1182/BLOOD-2012-03-415364
P407
P577
2012-04-27T00:00:00Z